Immunotherapy and the implementation of more aggressive treatment schemes for locally advanced hepatocellular carcinomas have expanded the boundaries of curative options. Because of these advancements, patients who were once considered beyond the aim of a cure are now eligible for liver transplantation and resection.
Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma / Ferraro, Daniele; Falaschi, Federica; Nazzaro, Luca; Vennarecci, Giovanni. - In: WORLD JOURNAL OF GASTROENTEROLOGY. - ISSN 1007-9327. - 30:28(2024), pp. 3452-3455. [10.3748/wjg.v30.i28.3452]
Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma
Ferraro, Daniele
Writing – Original Draft Preparation
;Falaschi, FedericaWriting – Review & Editing
;
2024
Abstract
Immunotherapy and the implementation of more aggressive treatment schemes for locally advanced hepatocellular carcinomas have expanded the boundaries of curative options. Because of these advancements, patients who were once considered beyond the aim of a cure are now eligible for liver transplantation and resection.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
